dipyridamole has been researched along with Dyskinesia, Drug-Induced in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of haloperidol (1 mg/kg, i." | 1.34 | Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2007) |
| "Dipyridamole was administered orally, daily 30 min before IDPN in the doses of 0." | 1.29 | Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats. ( al-Deeb, S; al-Moutaery, K; Arshaduddin, M; Bruyn, GW; Evans, DA; Tariq, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Tariq, M | 1 |
| al-Deeb, S | 1 |
| al-Moutaery, K | 1 |
| Bruyn, GW | 1 |
| Evans, DA | 1 |
| Arshaduddin, M | 1 |
2 other studies available for dipyridamole and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Topics: Animals; Behavior, Animal; Brain; Catalase; Dipyridamole; Dopamine; Dose-Response Relationship, Drug | 2007 |
Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats.
Topics: Animals; Behavior, Animal; Brain Chemistry; Chromatography, High Pressure Liquid; Dipyridamole; Dysk | 1995 |